News

Exclusive-US pharma tariffs would raise US drug costs by $51 billion annually, report finds
The analysis, conducted by Ernst & Young (EY), found the United States imported $203 billion in pharmaceutical products in ...
SLV: While Gold Is In The Spotlight, This Precious Metal Is Forgotten
I recommend buying the iShares Silver Trust ETF (NYSEARCA:SLV) due to silver's compelling risk-return profile compared to ...